Related Experiment Video
Updated: Jun 23, 2026

Modeling Paracrine Noncanonical Wnt Signaling In Vitro
Published on: December 10, 2021
Normal growth and development in mice over-expressing the CCN family member WISP3
Yukio Nakamura1, Yajun Cui, Carol Fernando
1Howard Hughes Medical Institute, Orthopaedic Research Laboratories, Department of Orthopaedic Surgery and Genetics, Children's Hospital and Harvard Medical School, Boston, MA, USA, yukio.nakamura@childrens.harvard.edu.
Abstract:
Loss-of-function mutations in the gene WISP3 cause the autosomal recessive human skeletal disease Progressive Pseudorheumatoid Dysplasia, whereas mice with knockout mutations of Wisp3 have no phenotype. The lack of a phenotype in the Wisp3 knockout mice has constrained studies of the protein's in vivo function. Over-expression experiments in zebrafish indicated that WISP3 may function as a BMP and Wnt signaling modulator. To determine whether these biologic activities are retained in mice, we created two strains of transgenic mice that over-express WISP3 in a broad array of tissues. Despite strong and persistent protein over-expression, the transgenic mice remained phenotypically indistinguishable from their non-transgenic littermates. Surprisingly, WISP3 contained in conditioned medium recovered from transgenic mouse primary kidney cell cultures was able to bind BMP and to inhibit BMP signaling in vitro. Factors that account for the difference between the in vitro and in vivo activities of WISP3 remain unknown. At present, the mouse remains a challenging model organism in which to explore the biologic function of WISP3. Summary of article. Transgenic mice that broadly over-express WISP3 were created to search for in vivo biologic activities, since mice that lack WISP3 were normal. Surprisingly, transgenic mice were also phenotypically indistinguishable from wild-type animals. The mouse is a challenging model organism in which to explore the biologic function of WISP3.
Insights
WISP3 protein, implicated in human skeletal disease, showed no effects in transgenic mice despite overexpression. In vitro studies suggest WISP3 may modulate BMP signaling, but in vivo function remains elusive in mice.
Area of Science:
- Biochemistry
- Genetics
- Developmental Biology
Background:
- Loss-of-function mutations in WISP3 cause Progressive Pseudorheumatoid Dysplasia in humans.
- WISP3 knockout mice exhibit no discernible phenotype, limiting in vivo functional studies.
- Zebrafish studies suggest WISP3 modulates BMP and Wnt signaling pathways.
Purpose of the Study:
- To investigate the in vivo biological activities of WISP3 in mice.
- To determine if WISP3's potential BMP and Wnt signaling modulation observed in zebrafish is retained in mice.
Main Methods:
- Creation of two transgenic mouse strains overexpressing WISP3 broadly.
- Phenotypic analysis of transgenic mice compared to non-transgenic littermates.
- In vitro analysis of WISP3 from conditioned medium of primary kidney cell cultures.
Main Results:
- Transgenic mice overexpressing WISP3 showed no phenotypic differences from wild-type mice.
- WISP3 in conditioned medium bound BMP and inhibited BMP signaling in vitro.
- Persistent, strong WISP3 overexpression did not alter mouse phenotype.
Conclusions:
- The mouse model presents challenges for studying WISP3's in vivo biological function.
- Discrepancies between in vitro and in vivo WISP3 activity require further investigation.
- The precise in vivo role of WISP3 remains undetermined despite overexpression studies.
Related Concept Videos
Canonical Wnt Signaling Pathway
Hedgehog Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

